Journal article
GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19‐TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)—AN INTERIM ANALYSIS
Authors
Schuster SJ; Bishop MR; Tam C; Waller EK; Borchmann P; Mcguirk J; Jäger U; Jaglowski S; Andreadis C; Westin J
Journal
Hematological Oncology, Vol. 35, No. S2, pp. 27–27
Publisher
Wiley
Publication Date
June 1, 2017
DOI
10.1002/hon.2437_6
ISSN
0278-0232